Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025

Rhea-AI Summary

Journey Medical (Nasdaq: DERM) will release third quarter 2025 financial results after U.S. markets close on Wednesday, November 12, 2025. Management will host a conference call and live audio webcast the same day at 4:30 p.m. ET to discuss results and provide a corporate update.

Domestic dial-in is 1-866-777-2509, international dial-in is 1-412-317-5413. Participants may register at the provided registration link and a live webcast will be available on the Investors > News and Events page with replay accessible for approximately 30 days.

Company to host conference call to discuss financial results and provide a corporate update on November 12, 2025 at 4:30 p.m. ET

SCOTTSDALE, Ariz., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced the Company will release its third quarter 2025 financial results after the U.S. financial markets close on Wednesday, November 12, 2025. Journey Medical management will conduct a conference call and audio webcast on Wednesday, November 12, 2025 at 4:30 p.m. ET.

To listen to the conference call, interested parties within the U.S. should dial 1-866-777-2509 (domestic) or 1-412-317-5413 (international). All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to join the Journey Medical conference call. Participants can register for the conference by navigating to https://dpregister.com/sreg/10204065/100324a2b1b. Please note that registered participants will receive their dial-in number upon registration.

A live audio webcast can be accessed on the News and Events page of the Investors section of Journey Medical’s website, www.journeymedicalcorp.com, and will remain available for replay for approximately 30 days after the conference call.

About Journey Medical Corporation
Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”) is a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions through its efficient sales and marketing model. The Company currently markets eight branded FDA-approved prescription drugs that help treat and heal common skin conditions. The Journey Medical team comprises industry experts with extensive experience in developing and commercializing some of dermatology’s most successful prescription brands. Journey Medical is located in Scottsdale, Arizona and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). Journey Medical’s common stock is registered under the Securities Exchange Act of 1934, as amended, and it files periodic reports with the U.S. Securities and Exchange Commission (“SEC”). For additional information about Journey Medical, visit www.journeymedicalcorp.com.

Company Contact:
Jaclyn Jaffe
Journey Medical Corporation
(781) 652-4500
ir@jmcderm.com

Media Relations Contact:
Tony Plohoros
6 Degrees
(908) 591-2839
tplohoros@6degreespr.com  

FAQ

When will Journey Medical (DERM) release Q3 2025 results and hold the conference call?

Results will be released after U.S. market close on November 12, 2025, with a conference call and webcast at 4:30 p.m. ET that day.

How can I join the Journey Medical (DERM) conference call on November 12, 2025?

Dial 1-866-777-2509 (U.S.) or 1-412-317-5413 (international) and ask to join the Journey Medical conference call; dial in ~10 minutes early.

Where do I register for the Journey Medical (DERM) Q3 2025 conference call?

Register at the provided registration URL so registered participants receive their dial-in number upon registration.

Will Journey Medical (DERM) provide a live webcast of the November 12, 2025 call?

Yes. A live audio webcast will be available on the Investors section News and Events page of the company website.

How long will the Journey Medical (DERM) webcast replay be available after the November 12, 2025 call?

The webcast replay will remain available for approximately 30 days after the conference call.

What time should I call to join Journey Medical's November 12, 2025 conference call?

Call approximately 10 minutes prior to the scheduled 4:30 p.m. ET start time to ensure connection.